We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Test Reveals Existing Antibiotics Can Cure Superbugs

By LabMedica International staff writers
Posted on 02 May 2023

A new test has revealed that FDA-approved antibiotics, readily available at local pharmacies, can effectively combat superbugs. More...

These antibiotics are not prescribed due to the gold-standard test indicating their inefficacy. This novel test could revolutionize the development, testing, and prescription of antibiotics, playing a crucial role in the battle against bacterial resistance by optimizing the use of existing antibiotics and bolstering the search for new ones.

The antibiotic study by a team of scientists at UC Santa Barbara (Santa Barbara, CA, USA) tackled a fundamental issue in the current healthcare approach to determining antibiotic resistance, which fails to consider the environmental conditions within the body that influence drug efficacy. By replicating these conditions, the new test pinpointed several effective antibiotics that standard testing had dismissed. When both the new and standard tests concurred, a near-perfect prediction of treatment success or failure emerged. The study involved extensive screening of over 500 antibiotic-bacteria combinations, with the findings indicating that the standard test is inaccurate approximately 15% of the time. Since doctors depend on this test to guide treatment decisions, it may result in the prescription of inappropriate antibiotics.

Medical professionals are aware of the gold-standard test's limitations. When the suggested antibiotics prove ineffective, physicians must draw upon their experience to determine the most suitable antibiotic(s) for their patients. This study offers a potential solution to bridge the gap between the antibiotics suggested by standard testing and actual patient outcomes. The new test could lead to substantial cost savings for the healthcare sector as they endeavor to identify novel drugs to combat antimicrobial-resistant infections.

“Reevaluation of FDA-approved antibiotics may be of far greater benefit than the time and cost of developing new drugs to combat antimicrobial resistance,” explained Santa Barbara Cottage Hospital physician Lynn Fitzgibbons, M.D., “potentially leading to significant life-savings and cost-savings.”

Related Links:
UC Santa Barbara 


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.